David Anderson, MD, on Systemic Tx vs Surgery for De Novo Stage IV Breast Cancer
David Anderson, MD, and Elisa Port, MD, discuss their findings on systemic Tx vs surgery for de novo stage IV breast cancer at the ASCO Annual Meeting.
Press Release
The Tisch Cancer Institute Emphasizes Critical Role of BRCA Testing For All Genders
Oct 14, 2024 View All Press ReleasesPress Release
Mount Sinai’s Dubin Breast Center Annual Benefit Raises Over $2.5 Million
Feb 08, 2022 View All Press Releases